• Avaliação Econômica do Interferon Peguilado Alfa 2a em Combinação com a Ribavirina para o Tratamento da Infecção Pelo Genótipo 1 da Hepatite Crônica C- Comparação do Tratamento por 48 Semanas e Terapia Estendida

    Dec 1, 2013, 00:00

  • Guide for Authors

    Dec 1, 2013, 00:00

  • Análisis del Proceso de Actualización de Medicamentos en el Cuadro Básico y Catálogo de Insumos del Sector Salud

    Dec 1, 2013, 00:00

  • Estándares Consolidados de Reporte de Evaluaciones Económicas Sanitarias- Versión en Español de la Lista de Comprobación CHEERS

    Dec 1, 2013, 00:00

  • Lista de Comprobación CHEERS11Consolidated Health Economic Evaluation Reporting Standards. en Españ̆ol- Estándares Consolidados de Reporte de Evaluaciones Económicas Sanitarias

    Dec 1, 2013, 00:00

  • Dengue Epidemiology and Burden of Disease in Latin America and the Caribbean- A Systematic Review of the Literature and Meta-Analysis

    Dec 1, 2013, 00:00

  • Reviewer Acknowledgment

    Dec 1, 2013, 00:00

  • The Impact of Psychotropic Drug Costs on the Brazilian Family Budget- An Analysis of the Family Budget Surveys of 2003 and 2009

    Dec 1, 2013, 00:00

  • Table of Contents

    Dec 1, 2013, 00:00

  • Copyright/Subscription

    Dec 1, 2013, 00:00

  • Costo-Efectividad de la Proteína C Reactiva, Procalcitonina y Escala de Rochester- Tres Estrategias Diagnosticas para la Identificación de Infección Bacteriana Severa en Lactantes Febriles sin Foco

    Dec 1, 2013, 00:00

  • Carga de la Enfermedad Atribuible al Síndrome de Túnel del Carpo en la Población Trabajadora Colombiana- Una Aproximación a los Costos Indirectos de una Enfermedad

    Dec 1, 2013, 00:00

  • Impact of the Pharma Economic Act on Diffusion of Innovation and Reduction of Costs in the Hungarian Prescription Drug Market (2007–2010)

    Sep 1, 2013, 00:00

  • Table of Contents

    Sep 1, 2013, 00:00

  • Cost-Utility Analysis of Depot Atypical Antipsychotics for Chronic Schizophrenia in Croatia

    Sep 1, 2013, 00:00

  • Transforming Public Servants’ Health Care Organization in Greece through the Implementation of an Electronic Referral Project

    Sep 1, 2013, 00:00

  • The Impact of Pharmaceutical Care Intervention on the Quality of Life of Nigerian Patients Receiving Treatment for Type 2 Diabetes

    Sep 1, 2013, 00:00

  • The Methodological Challenges for the Estimation of Quality of Life in Children for Use in Economic Evaluation in Low-Income Countries

    Sep 1, 2013, 00:00

  • Editorial Board

    Sep 1, 2013, 00:00

  • Performance Assessment of Ga District Mutual Health Insurance Scheme, Greater Accra Region, Ghana

    Sep 1, 2013, 00:00

  • Cost for Treatment of Chronic Lymphocytic Leukemia in Specialized Institutions of Ukraine

    Sep 1, 2013, 00:00

  • Further Steps in the Development of Pharmacoeconomics, Outcomes Research, and Health Technology Assessment in Central and Eastern Europe, Western Asia, and Africa

    Sep 1, 2013, 00:00

  • The Process of Privatization of Health Care Provision in Poland

    Sep 1, 2013, 00:00

  • Patient-Reported Quality of Life During Antiretroviral Therapy in a Nigerian Hospital

    Sep 1, 2013, 00:00

  • What Influences Recommendations Issued by the Agency for Health Technology Assessment in Poland? A Glimpse Into Decision Makers’ Preferences

    Sep 1, 2013, 00:00

  • Children Hospitalized for Varicella- Complications and Cost Burden

    Sep 1, 2013, 00:00

  • Guide for Authors

    Sep 1, 2013, 00:00

  • Recommendations for Reporting Pharmacoeconomic Evaluations in Egypt

    Sep 1, 2013, 00:00

  • Capacity Building for HTA Implementation in Middle-Income Countries- The Case of Hungary

    Sep 1, 2013, 00:00

  • Dossier System as a Practical Tool for Compiling Reimbursement Lists

    Sep 1, 2013, 00:00

  • Cost-Utility Analysis of Pharmaceutical Care Intervention Versus Usual Care in Management of Nigerian Patients with Type 2 Diabetes

    Sep 1, 2013, 00:00

  • Costs of Medically Attended Acute Gastrointestinal Infections- The Polish Prospective Healthcare Utilization Survey

    Sep 1, 2013, 00:00

  • An Audit of Diabetes-Dependent Quality of Life (ADDQOL) in Older Patients with Diabetes Mellitus Type 2 in Slovenia

    Sep 1, 2013, 00:00

  • Radiology Services Costs and Utilization Patterns Estimates in Southeastern Europe—A Retrospective Analysis from Serbia

    Sep 1, 2013, 00:00

  • Response to “Potential Regulatory and Commercial Environment for Biosimilars in Latin America” by Azevedo et al.

    Sep 1, 2013, 00:00

  • A Framework for Applying Health Technology Assessment in Cyprus- Thoughts, Success Stories, and Recommendations

    Sep 1, 2013, 00:00

  • Economic Burden of Cardiovascular Diseases in the Russian Federation

    Sep 1, 2013, 00:00

  • ERRATUM

    Sep 1, 2013, 00:00

  • Reviewer Acknowledgement

    Sep 1, 2013, 00:00

  • Note from the Editors

    Sep 1, 2013, 00:00

  • Clinical Burden of Invasive Pneumococcal Disease in Selected Developing Countries

    Sep 1, 2013, 00:00

  • Copyright/Subscription

    Sep 1, 2013, 00:00

  • Response to Letter from Dr. Jorge Revilla Beltri dated 22nd March, 2013

    Sep 1, 2013, 00:00

  • Systematic Review of Economic Evaluation Literature in Ghana- Is Health Technology Assessment the Future?

    Sep 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Aripiprazole Augmentation Treatment of Patients with Major Depressive Disorder Compared to Olanzapine and Quetiapine Augmentation in Turkey- A Microsimulation Approach

    Sep 1, 2013, 00:00

  • Assessment of Costs Associated with Hospital-Acquired Infections in a Private Tertiary Care Hospital in India

    May 1, 2013, 00:00

  • Epidemiology and Disease Burden of Ulcerative Colitis in Taiwan- A Nationwide Population-Based Study

    May 1, 2013, 00:00

  • Economic Burden of Individual Suffering from Atrial Fibrillation–Related Stroke in China

    May 1, 2013, 00:00

  • Guide for Authors

    May 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Asthma in Japan and the Value of Responder Prediction Methods Based on a Multinational Trial

    May 1, 2013, 00:00

  • Table of Contents

    May 1, 2013, 00:00

  • A Novel Estimation of the Impact of Treatment with Entecavir on Long-Term Mortality, Morbidity, and Health Care Costs of Chronic Hepatitis B in China

    May 1, 2013, 00:00

  • The Health Economic Impact of Universal Infant Vaccination with the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine as Compared with 13-Valent Pneumococcal Conjugate Vaccine in Hong Kong

    May 1, 2013, 00:00

  • Copyright/Subscription

    May 1, 2013, 00:00

  • Cost-Effectiveness of Clinical Pharmacy Education on Infection Management among Patients with Chronic Kidney Disease in an Indonesian Hospital

    May 1, 2013, 00:00

  • A Cost-Effectiveness Analysis between Amlodipine and Angiotensin II Receptor Blockers in Stroke and Myocardial Infarction Prevention among Hypertension Patients in China

    May 1, 2013, 00:00

  • The Cost-Effectiveness Analysis of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) for Females in Japan

    May 1, 2013, 00:00

  • Assessment of Adverse Events and Quality of Life of Cancer Patients in a Secondary Level Care, Rural Hospital in South India

    May 1, 2013, 00:00

  • Burden of Disease Studies in the Asia-Pacific Region- Are There Enough being Performed to Provide Information for Evidence-Based Health Policy?

    May 1, 2013, 00:00

  • Reviewer Acknowledgment

    May 1, 2013, 00:00

  • What Is Important During the Selection of Traditional Chinese Medicine (TCM) in a Health Care Reimbursement or Insurance System?” Critical Issues of Assessment from the Perspective of TCM Practitioners

    May 1, 2013, 00:00

  • Equity in Pharmaceutical Pricing and Reimbursement- Crossing the Income Divide in Asia Pacific

    May 1, 2013, 00:00

  • Emerging Hub for Pharmacoeconomics and Outcomes Research- Asia-Pacific Region

    May 1, 2013, 00:00

  • Economic Evaluation of Lipid-Lowering Therapy in the Secondary Prevention Setting in the Philippines

    May 1, 2013, 00:00

  • Economic Evaluation of Pravastatin for Primary Prevention of Coronary Artery Disease Based on Risk Prediction from JALS-ECC in Japan

    May 1, 2013, 00:00

  • Increasing Anti-Infective Drug Expenditure in Tianjin, China- A Decomposition Analysis

    May 1, 2013, 00:00

  • Clinical Characterization and the Caregiver Burden of Dementia in China

    May 1, 2013, 00:00

  • Economic Impact of Venous Thromboembolism Following Major Orthopaedic Surgery in Japan

    May 1, 2013, 00:00

  • Cost-Effectiveness Analysis of a Screening Program for Breast Cancer in Vietnam

    May 1, 2013, 00:00

  • The Factors Contributing to Expenditures on Over-the-Counter Drugs in South Korea

    May 1, 2013, 00:00

  • Validity and Reliability of KDQOL-36 in Thai Kidney Disease Patient

    May 1, 2013, 00:00

  • Future Prospects for Pharmacoeconomics and Outcomes Research in the Emerging Regions

    May 1, 2013, 00:00

  • Health-Related Quality of Life among Nonprescription Medicine Customers in Malaysia

    May 1, 2013, 00:00

  • Editorial Board

    May 1, 2013, 00:00

  • Analysis of Excess Direct Medical Costs of Vision Impairment in Taiwan

    May 1, 2013, 00:00

  • Burden of Disease and Economic Impact of Dengue and Severe Dengue in Colombia, 2011

    Dec 1, 2012, 00:00

  • Guide for Authors

    Dec 1, 2012, 00:00

  • An Estimate of the Cost of Hepatitis C Treatment for the Brazilian Health System

    Dec 1, 2012, 00:00

  • Colombian Health System on its Way to Improve Allocation Efficiency—Transition from a Health Sector Reform to the Settlement of an HTA Agency

    Dec 1, 2012, 00:00

  • Economic Burden of Incident Unplanned Starts on Peritoneal Dialysis in a High Specialty Health Care Facility in Mexico City

    Dec 1, 2012, 00:00

  • Editorial Board

    Dec 1, 2012, 00:00

  • Table of Contents

    Dec 1, 2012, 00:00

  • Reviewer Acknowledgement

    Dec 1, 2012, 00:00

  • Consideraciones Regulatorias sobre Productos Biológicos en Brasil

    Dec 1, 2012, 00:00

  • Impacto de Dos Métodos Alternativos de Asignación de Costos Indirectos Estructurales de Hospitales Públicos Chilenos en el Costo Final de Producción de Servicios Sanitarios

    Dec 1, 2012, 00:00

  • Status Update of the Reimbursement Review Environment in the Public Sector across Four Latin American Countries

    Dec 1, 2012, 00:00

  • Cost Utility of Sirolimus versus Tacrolimus for the Primary Prevention of Graft Rejection in Renal Transplant Recipients in Mexico

    Dec 1, 2012, 00:00

  • Análisis de Costo-Efectividad de las Estrategias de Tamización de Cáncer Colorrectal en Colombia

    Dec 1, 2012, 00:00

  • Costo Efectividad del Tratamiento de Tumores Neuroendócrinos Pancreáticos Avanzados no Operables con Sunitinib en México

    Dec 1, 2012, 00:00

  • The Cost-Effectiveness and Budget Impact of Introducing Indacaterol into the Colombian Health System

    Dec 1, 2012, 00:00

  • Institutionalizing Health Technology Assessment in Brazil- Challenges Ahead

    Dec 1, 2012, 00:00

  • Cost-Effectiveness of Routine Screening for Cardiac Toxicity in Patients Treated with Imatinib in Brazil

    Dec 1, 2012, 00:00

  • Criterios Farmacoeconómicos Usados en México para la Evaluación de Tratamientos en Personas en Fases Terminales

    Dec 1, 2012, 00:00

  • Copyright/Subscription

    Dec 1, 2012, 00:00

  • Concurrent Validity and Reliability of the Brazilian Version of the Functioning Assessment Short Test in Patients with Schizophrenia

    Dec 1, 2012, 00:00

  • Análisis Costo Efectividad del Stent Farmacológico V/S Stent no Farmacológico en Cardiopatía Isquémica en Chile

    Dec 1, 2012, 00:00

  • Diferenciación en la Evaluación Económica Tradicional para Medicamentos que se Utilizan en Fases Terminales, Recomendaciones Recientes del Reino Unido y su Consideración para México y otros Países

    Dec 1, 2012, 00:00

  • Análisis de Costo Efectividad de Estrategias de Tratamiento Antimicótico en Pacientes con Neutropenia Febril Persistente y Tratamiento Antibiótico de Amplio Espectro

    Dec 1, 2012, 00:00

  • Prevalence, Awareness, Treatment, and Burden of Major Depressive Disorder- Estimates from the National Health and Wellness Survey in Brazil

    Dec 1, 2012, 00:00

  • Bloodstream Infection in the Intensive Care Unit- Preventable Adverse Events and Cost Savings

    Dec 1, 2012, 00:00

  • Performing Country-led Economic Evaluations to Inform Immunization Policy- ProVac Experiences in Latin America and the Caribbean

    Dec 1, 2012, 00:00

  • Economic Evaluation of Bariatric Surgery in Mexico Using Discrete Event Simulation

    Dec 1, 2012, 00:00

  • Potential Regulatory and Commercial Environment for Biosimilars in Latin America

    Dec 1, 2012, 00:00

  • Patient Utility Measurement for Managing Ureteral Stones- A Modified Standard Gamble Approach

    May 1, 2012, 00:00

  • How Does Out-of-Pocket Payment Affect Choices When Accessing Health Care?—A Qualitative Study on Hypertensive Outpatients in Southern Taiwan

    May 1, 2012, 00:00

  • The Cost of Providing HIV/AIDS Counseling and Testing Services in Vietnam

    May 1, 2012, 00:00

  • Economic Evaluation of Rehabilitation Services for Inpatients with Stroke in Thailand- A Prospective Cohort Study

    May 1, 2012, 00:00

  • Attributable Cost and Length of Stay for Patients with Enoxaparin-Associated Bleeding

    May 1, 2012, 00:00

  • Are English and Chinese Versions of the Audit of Diabetes-Dependent Quality of Life Equivalent? An Exploratory Study Based on the Universalist Approach

    May 1, 2012, 00:00

  • Cost of Illness of Chronic Hepatitis B Infection in Vietnam

    May 1, 2012, 00:00

  • Validation of the Schizophrenia Quality of Life Scale Revision 4 among Chronic Schizophrenia Patients in Malaysia

    May 1, 2012, 00:00

  • Health State Utility Assessment for Breast Cancer

    May 1, 2012, 00:00

  • Generalized Cost-Effectiveness Analysis of Pharmaceutical Interventions for Primary Prevention of Cardiovascular Disease in Thailand

    May 1, 2012, 00:00

  • Copyright/Subscription

    May 1, 2012, 00:00

  • Editorial Board

    May 1, 2012, 00:00

  • Table of Contents

    May 1, 2012, 00:00

  • Reconciling Cancer Care Costs Reported by Different Government Agencies in Taiwan- Why Costing Approach Matters?

    May 1, 2012, 00:00

  • Cost Assessment of Implementation of Immune Tolerance Induction in Iran

    May 1, 2012, 00:00

  • Drug Utilization Reviews by Community Pharmacists in Japan- Identification of Potential Safety Concerns through the Brown Bag Program

    May 1, 2012, 00:00

  • Cost-Effectiveness Analysis of Hepatitis B Immunization in Vietnam- Application of Cost-Effectiveness Affordability Curves in Health Care Decision Making

    May 1, 2012, 00:00

  • Reviewer Acknowledgment

    May 1, 2012, 00:00

  • Guide for Authors

    May 1, 2012, 00:00

  • Cost-Effectiveness of Sertindole among Atypical Antipsychotics in the Treatment of Schizophrenia in South Korea

    May 1, 2012, 00:00

  • Aprepitant for Patients Receiving Highly Emetogenic Chemotherapy- An Economic Analysis for Singapore

    May 1, 2012, 00:00

  • Widening Horizon of Pharmacoeconomics and Outcomes Research in the Asia-Pacific Region

    May 1, 2012, 00:00

  • Health Care System Information Sharing- A Step Toward Better Health Globally

    May 1, 2012, 00:00

  • Economic Evaluation of Anastrozole Versus Tamoxifen for Early Stage Breast Cancer in Singapore

    May 1, 2012, 00:00

  • Factors Influencing Oral Coxibs Utilization and Expenditure at a Thai Teaching Hospital, Fiscal Year 2007 to 2009

    May 1, 2012, 00:00
  • «
  • 11
  • 12 (current)